CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Sólido margen EBIT ajustado del 18,8 %, impulsado por un firme crecimiento orgánico de los ingresos del 7,4 %

EarningsPositive
AI Analysis

Summary

CERS reported first half 2026 results with 7.4% organic revenue growth and 18.8% adjusted EBIT margin, driven by contributions from both companion animal and farm animal segments.

Financial Highlights

Revenue

+7.4% organic growth

Importance:2/10
Sentiment:
0.60
earningsfinancial_resultsrevenue_growthEBIT_marginfirst_half_2026

Read the original article

Published by PR Newswire Biotech on September 18, 2026 11:27 AM

Read Original